Major Depressive Disorder

July 10th 2024

Despite extensive research into patient-level differences in antidepressant treatment outcomes, the variability among clinicians themselves hasn’t been thoroughly evaluated.

December 24th 2022

The top 5 most-read articles on major depressive disorder (MDD) in 2022 discussed US treatment updates, drug assistance in talk therapy, further exploration of transcranial magnetic stimulation’s capabilities, and screening improvements and outcomes.

December 19th 2022

Having lower levels of a personality traits know as personal reserve was linked with an increased probability of sustained remission (SR) in patients with major depressive disorder.

December 18th 2022

While the combination improved multiple depression scores, patients receiving both therapies did have more adverse events than those in control groups, the meta-analysis found.